PATENT CLAIM ANALYSIS

Application Number: 16060641
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "210210"]

Abstract:
The present invention relates to LpxC antibacterial compounds of Formula (IA): corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, compound preparation, treatment methods and uses for bacterial infections, especially those caused by gram-negative bacteria.

Claim (Index 19):
The method of treating a bacterial infection according to  claim 15 , wherein the Gram negative bacteria selected from Gram negative bacteria of enterobacteria, Gram negative bacteria colonized in respiratory, Gram negative bacteria of glucose non fermentation or drug resistant Gram negative bacteria.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 94.0
- Lexical Diversity: 1.10526
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14004105', '14068956', '14154239', '13515607', '14110165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7829723908781392
- 35 USC 102 Novelty (BERT): 0.5489358107542169
- Combined Prediction Score: 0.759568732865747
- Mean Citation Score: 356.35282599999994
- Max Citation Score: 394.587
- Similarity Product: 280.775763830781

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test